Cardiovascular Safety of Atomoxetine and Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder in Japan: A Self-Controlled Case Series Study
Journal of Attention Disorders · 2024
DOI: 10.1177/10870547231214993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Attention Disorders, 2024. Verfasst von Yunlong Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Japan. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Methylphenidate, Central Nervous System Stimulants, Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Objective
To investigate the association between atomoxetine or methylphenidate use and arrhythmia, heart failure (HF), stroke, and myocardial infarction (MI) in attention-deficit/hyperactivity disorder (ADHD) patients mainly focused on the people of working age.
Methods
In a self-controlled case series study using a Japanese claims database, we identified events of arrhythmia, HF, stroke, and MI among 15,472 atomoxetine new users and 12,059 methylphenidate new users. Adjusted incidence rate ratios (aIRRs) of outcome events were estimated using multivariable conditional Poisson regression.
Results
An increased risk of arrhythmia was observed during the first 7 days after the initial atomoxetine exposure (aIRR 6.22, 95% CI [1.90, 20.35]) and in the subsequent exposure (3.23, [1.58, 6.64]). No association was found between methylphenidate exposure and arrhythmia, nor between atomoxetine or methylphenidate exposure and HF. The limited number of stroke and MI cases prevented thorough analysis.
Conclusions
Clinicians should consider monitoring for arrhythmia after patients initiating or re-initiating atomoxetine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Japan.
- Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Japan.
ORCID-Profile: Yunlong Zheng, Toshiki Fukasawa, Koji Kawakami
Zitieren
APA
Zheng, Y., Fukasawa, T., Yamaguchi, F., Takeuchi, M., & Kawakami, K. (2024). Cardiovascular Safety of Atomoxetine and Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder in Japan: A Self-Controlled Case Series Study. Journal of Attention Disorders. https://doi.org/10.1177/10870547231214993
Vancouver
Zheng Y, Fukasawa T, Yamaguchi F, Takeuchi M, Kawakami K. Cardiovascular Safety of Atomoxetine and Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder in Japan: A Self-Controlled Case Series Study. Journal of Attention Disorders. 2024. doi:10.1177/10870547231214993
BibTeX
@article{Zheng2024,
author = {Zheng, Yunlong and Fukasawa, Toshiki and Yamaguchi, Fumitaka and Takeuchi, Masato and Kawakami, Koji},
title = {Cardiovascular Safety of Atomoxetine and Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder in Japan: A Self-Controlled Case Series Study},
journal = {Journal of Attention Disorders},
year = {2024},
doi = {10.1177/10870547231214993}
}
EUVIMED